Picture Stier Group MIXiii Lifescience Healthtech Conference 650x100px

Document › Details

Fluidigm Corporation. (2/14/18). "Press Release: Fluidigm to Participate in Upcoming Health Care Investor Conferences". South San Francisco, CA.

	Region	Boston, MA
	Country	United States (USA)
	Organisation	Fluidigm Corporation (Nasdaq: FLDM)
	Group	Fluidigm (Group)
	Organisation 2	Cowen & Company LLC
	Product	Cowen & Co. Annual Health Care Conference 2018 Boston
	Product 2	BTIG Healthcare Conference 2018 Snowbird UT
	Index term	Fluidigm–BTIG: investor conference, 201803 supply service Fluidigm participates in Annual BTIG Healthcare Conference 2018
	Index term 2	Fluidigm–Cowen: investor conference, 201803 supply service Fluidigm presents at Cowen & Co Annual Health Care Conference 2018
	Person	Linthwaite, S. Christopher (Chris) (Fluidigm 201610– CEO joined 201608 as COO before Thermo Fisher + Life Technologies)
	Person 2	Jog, Vikram (Fluidigm 200802– CFO before XDx CFO + Applera)

Fluidigm Corporation (NASDAQ:FLDM) today announced that the company's management will participate in two upcoming investor conferences.

Chris Linthwaite, President and CEO, and Vikram Jog, Chief Financial Officer, will participate in the fifth annual BTIG Healthcare Conference, focused on medical technology, life sciences, and diagnostic tools, in Snowbird, Utah, on Wednesday, February 28, and Thursday, March 1.

Linthwaite and Jog will also participate in the Cowen and Company 38th Annual Health Care Conference at the Boston Marriott Copley Place in Boston, Massachusetts. Linthwaite will present on Tuesday, March 13, 2018, at 9:20 am ET, with a breakout to follow at 10:00 am ET.

A live webcast of the company's presentation and subsequent replay may be accessed at http://investors.fluidigm.com/events.cfm. The webcast will be archived for 90 days following the live presentation.

About Fluidigm

Fluidigm (NASDAQ:FLDM) develops, manufactures, and markets life science analytical and preparatory systems for markets such as mass cytometry, high-throughput genomics, and single-cell genomics. We sell to leading academic institutions, clinical research laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology companies worldwide. Our systems are based on proprietary microfluidics and multiparameter mass cytometry technology and are designed to significantly simplify experimental workflow, increase throughput, and reduce costs while providing excellent data quality. Fluidigm products are provided for Research Use Only. Not for use in diagnostic procedures.

Fluidigm and the Fluidigm logo are trademarks and/or registered trademarks of Fluidigm Corporation.

Contact:

Fluidigm Corporation

Ana Petrovic
Director, Corporate Development and Investor Relations
650 243 6628 (office)
ana.petrovic@fluidigm.com

Record changed: 2023-06-05